Abstract: Currently, drug screening relies on cell-based experiments or on animal models to confirm biological effects. The mammalian system is considered too time-consuming, expensive and complex to perform high-throughput drug screening. There is a gap between in vitro cell-based models and the in vivo mammalian models. The zebrafish is an ideal model that could link preclinical toxicity screening with the drug development pipeline. Taking advantage of a highly conservative genomic, rapid development, large number of offspring, low cost and easy manipulation, zebrafish has been considered an excellent animal model for disease-based drug screening. In this study, zebrafish embryos were incubated with small molecular compounds that potentially affected bone mineralization in microplates. Two compounds of alendronate and dorsomorphin were used as positive and negative controls, respectively. The level of osteogenic mineralization was measured and quantified by using ImageJ software with fluorescent calcein-staining images. Among twenty-four tested compounds from the kinase inhibitor library, we identified two compounds, pentamidine and BML-267, which showed increased embryonic mineralization; while six compounds, RWJ-60475, levamisole HCL, tetramisole HCL, fenvalerate, NSC-663284, and BML-267ester, were inhibitory to bone mineralization. In addition, real time quantitative PCR (RT-qPCR) was performed to evaluate the biological pathways involved in bone metabolism at the molecular level. We confirmed that alendronate enhanced the level of bone mineralization by inhibiting osteoclast-related genes. In summary, our research established a simple method to screen potential bone metabolic drugs and to perform mechanism analysis for bone mineralization in vivo.
Introduction
Bone, a dynamic organ that serves mechanical and homeostatic functions, undergoes a continual self-regeneration called remodeling [1] . Bone remodeling is a process specified by a balance between bone formation by osteoblasts and bone resorption by osteoclasts [2] . An imbalance in bone remodeling contributes to several pathologic conditions, including osteosclerosis, osteopetrosis, and osteoporosis [3] . Osteosclerosis is a bone disorder characterized by abnormal thickening and progressive increase in bone mass because of increased number of osteoblasts. In contrast, osteopetrosis results from a primary decrease in osteoclastic function [4] . Dorsomorphin, whose structure is shown in Figure 2C , inhibits Smad-dependent BMP (Bone morphogenetic protein) signaling, which has been shown to be a key promoter during osteogenesis [11, 21] . We hypothesized that dorsomorphin may serve as a negative regulator for bone mineralization. As the data showed, when we treated zebrafish embryos with dorsomorphin at various concentrations (10, 20 , and 30 µM) from 3 dpf onwards, we found that dorsomorphin caused decreased mineralization of vertebrate column in zebrafish larvae in a dose-dependent manner (Figure 2A ,B). Combined data collected from alendronate and dorsomorphin, we concluded the biological effect of both compounds on zebrafish bone mineralization is well consistent with the phenotype observed in their mammalian counterparts.
Figure 1. Evaluation of mineralization in alendronate-treated zebrafish. (A)
The gross morphology of zebrafish aged at 7 dpf which have been treated with different concentrations of alendronate (10, 20 , and 30 µM, left bright-filed panel) from 3 dpf onwards. Calcein staining on control and alendronate-treated embryos at 7 dpf (right green fluorescent panel); (B) Quantification of mineralization degree by detecting the fluorescence intensity at the area of centrum form ring in the notochord. (values are mean ± SD; tested by one-way ANOVA pairwise comparison; N = fish number; Different letters indicate significant differences) (C) Chemical structure of alendronate. Dorsomorphin, whose structure is shown in Figure 2C , inhibits Smad-dependent BMP (Bone morphogenetic protein) signaling, which has been shown to be a key promoter during osteogenesis [11, 21] . We hypothesized that dorsomorphin may serve as a negative regulator for bone mineralization. As the data showed, when we treated zebrafish embryos with dorsomorphin at various concentrations (10, 20 , and 30 µM) from 3 dpf onwards, we found that dorsomorphin caused decreased mineralization of vertebrate column in zebrafish larvae in a dose-dependent manner (Figure 2A,B) . Combined data collected from alendronate and dorsomorphin, we concluded the biological effect of both compounds on zebrafish bone mineralization is well consistent with the phenotype observed in their mammalian counterparts. (A) The gross morphology of zebrafish aged at 7 dpf which have been treated with different concentrations of dorsomorphin (10, 20 , and 30 µM, left bright-filed panel) from 3 dpf onwards.
Calcein staining on control and dorsomorphin-treated embryos aged at 7 dpf (right green fluorescent panel; (B) Quantification of mineralization degree detecting the fluorescence intensity at the area of centrum form ring in the notochord. (values are mean ± SD; tested by one-way ANOVA pairwise comparison; N = fish number; Different letters indicate significant differences) (C) Chemical structure of dorsomorphin.
Rapid Screening on Small Molecular Library
Inspired from the data of alendronate and dorsomorphin, we aimed to evaluate more compounds that might affect bone mineralization in zebrafish. We selected alkaline phosphatase inhibitor-like compounds in our chemical library. Zebrafish embryos aged at 3 dpf were treated with 10 µM of each compound, later the calcein staining was performed by 7 dpf. Compared to control group (in 0.1% DMSO), 12 out of 24 compounds showed embryonic toxicity. In addition, two compounds increased embryonic mineralization, while six compounds were inhibitory to bone mineralization ( Figure 3A ,B). Two compounds that caused increased vertebral area are pentamidine and BML-267. As a positive control, alendronate was also included for comparison. For pentamidine, zebrafish embryos aged at 3 dpf were treated with different concentrations and the mineralized areas were evaluated with calcein staining by 7 pdf ( Figure 4C ). The result showed that significant increase of bone mineralization was observed within zebrafish vertebral region ( Figure 4A,B) . Moreover, zebrafish treated with 10 µM pentamidine showed more pronounced mineralization than 30 µM treatment of alendronate. Therefore, we hypothesized that pentamidine is more potent to promote bone mineralization than alendronate. Next, we examined the mineralization effect on BML-267 ( Figure 5C ). Consistent with the increasing vertebral area observed at 10 µM of BML-267, the mineralization level of embryonic zebrafish was induced at 10 and 20 µM of BML-267 ( Figure 5A,B) . Interestingly, we have noticed an inhibitory effect of BML-267 at higher dose of 30 µM. The inhibitory effect of bone mineralization is not due to growth retardation in high BML-267 concentration, since the embryonic development seems normal from calcien staining. Further studies are required to clarify the inhibition phenomenon. Zebrafish embryos were treated with 10 µM of each compound from 3 dpf onwards. The quantification was determined with fluorescence microscopy within vertebrate column area after calcein staining. The blue column showed decreased mineralization after treating the specific compound; whereas red showed increased. (values are mean ± SD; * p < 0.05; ** p < 0.001; *** p < 0.001; tested by student's T test with 0.1% DMSO control group).
(B) Relative mineralization level of zebrafish embryos after treating with different compounds at 10 µM. Zebrafish embryos were treated with 10 µM of each compound from 3 dpf onwards. The quantification was determined with fluorescence microscopy within vertebrate column area after calcein staining. The blue column showed decreased mineralization after treating the specific compound; whereas red showed increased. (values are mean ± SD; * p < 0.05; ** p < 0.001; *** p < 0.001; tested by student's T test with 0.1% DMSO control group). Among the six compounds tested, RWJ-60475, levamisole HCL, tetramisole HCL, fenvalerate, NSC-663284, and BML-267ester showed the most inhibitory effect on mineralization ( Figure 3B) . A gradient of BML-267ester ( Figure 6C ) was chosen for validation of mineralization after treatment. As we expected, BML-267ester showed a dose-dependent decrease at mineralization level in embryonic zebrafish ( Figure 6A,B) . zebrafish aged at 7 dpf which have been treated with different concentrations of BML-267 (10, 20, and 30 µM, left bright-filed panel) from 3 dpf onwards. Calcein staining on control and BML-267-treated embryos at 7 dpf (right green fluorescent panel); (B) Quantification of mineralization degree detecting the fluorescence intensity at the area of centrum form ring in the notochord. (values are mean ± SD; tested by one-way ANOVA pairwise comparison; N = fish number; Different letters indicate significant differences) (C) Chemical structure of BML-267. 
Zebrafish Embryos are A Potential Drug-Screening and Mechanism-Analysis Platform for Bone Mineralization
Two processes are involved in bone formation: osteoblastic differentiation and osteoclastic inhibition. During osteoblastogenesis, mesenchymal stem cells (MSCs) are induced into osteoblasts, which proliferate and maturate into mineralized bone cells [22] . We next selected several genes that associated with bone development, and validated marker gene expression by RT-qPCR to confirm the affecting osteogenesis processes. Marker genes tested in this study are osteoclast-associated markers (ctsk, mmp9, rank, and acp5b), calcium absorption-related markers (trpv6, vdra, and vdrb), 
Two processes are involved in bone formation: osteoblastic differentiation and osteoclastic inhibition. During osteoblastogenesis, mesenchymal stem cells (MSCs) are induced into osteoblasts, which proliferate and maturate into mineralized bone cells [22] . We next selected several genes that associated with bone development, and validated marker gene expression by RT-qPCR to confirm the affecting osteogenesis processes. Marker genes tested in this study are osteoclast-associated markers (ctsk, mmp9, rank, and acp5b), calcium absorption-related markers (trpv6, vdra, and vdrb), osteoblast progenitor markers (runx2a, runx2b, and sp7), preosteoblast markers (alp, bmp2b, bmp4, and colla1a) and mature osteoblast markers (osteopontin, phex, and osteonectin). Compared with the control group, ctsk, mmp9, rank, and acp5b were significantly downregulated in alendronate treated embryos ( Figure 7) . Our results suggested that osteoclast-related pathway was generally inhibited when zebrafish embryos treated with alendronate. On the other hand, bmp2b and col1a1a were upregulated, which were consistent with increased bone formation seen in the clinical settings [23] . In addition, osteonectin (also known as sparc, is a glycoprotein that secreted by osteoblasts that binds calcium to initiate mineralization and promoting mineral crystal formation) was significantly upregulated, which has been reported to link to bone mineralization [24] . The major calcium uptake channel trpv6 [25] [26] [27] show no significant change in alendronate treated embryos, suggesting the increased level of mineralization is not contributing by the elevation of external calcium uptake. Phex is a transmembrane endopeptidase, thought to be involved in bone and dentin mineralization and renal phosphate reabsorption, showing un-expected downregulated in alendronate treated zebrafish embryos. In addition, the downregulated of alp and bmp4 in alendronate treated zebrafish embryos (showing elevation of mineralization level) is also unexpected. Currently, we do not know why phex, alp and bmp4 gene expression downregulated in alendronate treated zebrafish embryos. More studies should be addressed in the future to clarify this observation. Taken together, our data suggested alendronate triggered bone formation in zebrafish embryos through inhibition of osteoclast-associated signaling, and activated bone mineralization through bmp2b-osteonectin pathway.
reabsorption, showing un-expected downregulated in alendronate treated zebrafish embryos. In addition, the downregulated of alp and bmp4 in alendronate treated zebrafish embryos (showing elevation of mineralization level) is also unexpected. Currently, we do not know why phex, alp and bmp4 gene expression downregulated in alendronate treated zebrafish embryos. More studies should be addressed in the future to clarify this observation. Taken together, our data suggested alendronate triggered bone formation in zebrafish embryos through inhibition of osteoclast-associated signaling, and activated bone mineralization through bmp2b-osteonectin pathway. Total RNA was extracted from alendronate-treated embryos aged at 7 dpf and the relative expression levels of marker gene were measured by RT-qPCR. (N = 10; values are mean ± SD; * p < 0.05; ** p < 0.001; tested by student's t test with 0.1% DMSO control group).
Discussion
The bone formation process in zebrafish is like their mammalian counterparts, which consists of processes of intramembranous ossification and endochondral ossification [28] . The process of intramembranous ossification begins with the formation of interstitial stem cells in the cartilage, then the bone forms in the cartilage, and finally the cartilage is replaced by the bone. The flat bones that compose most of the skull are generated by intramembranous ossification. The intramembranous ossification process does not undergo the formation of cartilage. Rather, interstitial stem cells directly differentiate into osteoblasts, secrete extracellular matrices for mineralization, and finally form bones [29] . Bone formation processes are conserved in mammalian and fish systems, during both intramembranous and endochondral ossification within the craniofacial skeleton [30, 31] . The molecular mechanisms underlying the bone physiology are similar between two species [32] . However, there are several Total RNA was extracted from alendronate-treated embryos aged at 7 dpf and the relative expression levels of marker gene were measured by RT-qPCR. (N = 10; values are mean ± SD; * p < 0.05; ** p < 0.001; tested by student's t test with 0.1% DMSO control group).
The bone formation process in zebrafish is like their mammalian counterparts, which consists of processes of intramembranous ossification and endochondral ossification [28] . The process of intramembranous ossification begins with the formation of interstitial stem cells in the cartilage, then the bone forms in the cartilage, and finally the cartilage is replaced by the bone. The flat bones that compose most of the skull are generated by intramembranous ossification. The intramembranous ossification process does not undergo the formation of cartilage. Rather, interstitial stem cells directly differentiate into osteoblasts, secrete extracellular matrices for mineralization, and finally form bones [29] . Bone formation processes are conserved in mammalian and fish systems, during both intramembranous and endochondral ossification within the craniofacial skeleton [30, 31] . The molecular mechanisms underlying the bone physiology are similar between two species [32] . However, there are several differences in which zebrafish bone developments vary from those of rodents. The initial ossification events in the axial skeleton appeared at late larval stages, from 7 to 9 dpf, which were initially through an acellular rather than an endochondral mechanism [30] . Spinal cord development in zebrafish is also different from mammals, in that the spinal cord of a mammalian embryo was formed by intramembranous ossification during early development, while in zebrafish it was formed through endochondral ossification, without the formation of cartilage skeleton. As early as seven day-post-fertilization, part of the notochord began to mineralize, and formed the vertebrae directly. In addition, regional differences in the response of the zebrafish skeleton to BMP have been documented [33, 34] . The ossification processes within craniofacial region are similar to those in mammals. Osteoblasts and osteocytes both existed in larval zebrafish [30] . Therefore, larval zebrafish bones contained the sufficient and necessary cells for both bone formation and resorption activity. Compared to their high vertebrate counterparts, the translucent zebrafish embryos allow for direct observation of the mineralization process in vivo.
Generally, during preclinical drug mining, candidate validation and toxicity analysis is performed with in vitro cell-based approaches as first step. Later, by using the knowledge from in vitro assays, in vivo pharmacology and toxicology will be conducted and tested in a mammalian model [28, 29] . In vivo screening has been established for bone anabolic compounds in zebrafish by using non-vital dye of alizarin red [35] . The application of zebrafish on bone-related studies has been applied to some clinically well-known drugs, such as vitamin D3 (cholecalciferol), calcitriol, parathyroid hormone Teripalatide (Teriparatide), etc., which promote bone mineralization [35] . Previous study has proposed a rapid screening protocol by using calcein for the antagonist in Bone Morphogenetic Protein (BMP) signaling and found dorsomorphrin play an inhibitory role on bone mineralization in zebrafish larvae [11] . In this study, we examined more compounds and improved the methodology for calcein staining and performed an image-based rapid screening of zebrafish embryos for bone mineralization. Compared with alizarin red staining used by Fleming et al., 2005 [33] , the live fluorescent calcein-staining labels calcified skeletal structures, and it is a more sensitive and inclusive method for visualizing skeletal structures in developing zebrafish embryos. Recent study pointed out zebrafish operculum is a good target to assess osteogenic bioactivities [36] . In the operculum-based drug screen system, embryos were treated with chemicals from 3 dpf onwards and detect the mineralization level of operculum by alizarin red at 6 dpf. Although the timing and protocol between vertebrate column-based (this study) and operculum-based methods [36] are similar, however, the calcein dye used in our study is a vital dye and no need to sacrifice fish at the end of experiment. This vital dye method makes it is possible to detect biological events of zebrafish at phenotypic or molecular levels after the experimental endpoint.
As a pilot screening, we identified two compounds that can increase embryonic mineralization, while six compounds can inhibit bone mineralization (Figure 3 ). Although we processed the screening manually, our quantification screening with calcein staining indeed facilitated the process and diminished labor of handling. The contextual platform we provided may have the potential to scale up automation in the future. Furthermore, by using alendronate as a validation compound in our system, we demonstrated that phenotypic endpoints could corroborate with molecular tools such as RT-qPCR to characterize the mechanism of the candidates in a conceptual framework of cause-and-effect, with verifications from known molecular interactions and phenotypic anchoring. We examined several marker genes that are associated with bone development for the activities of these genes: osteoclast-associated markers, calcium absorption-related markers, osteoblast progenitor markers, preosteoblast markers, and mature osteoblast markers, to confirm the affected osteogenesis processes in alendronate treated embryos. The results suggested to us that the osteoclast-related pathway was generally inhibited. On the other hand, bmp2b and col1a1a were upregulated, which is consistent with increased bone formation seen in the clinical settings [23] . In this study, we have provided in vivo evidence to show alendronate triggers bone formation through inhibiting on osteoclast-associated signaling, and activates bone mineralization through a bmp2b-osteonectin pathway. By using a similar approach, we believe that the biological mechanism for other bone mineralization-promoting or -inhibiting drugs can be elucidated in future study. Taken together, our results demonstrate that zebrafish is a potential drug-screening and mechanism-analysis platform for bone mineralization in vivo. It has the advantage of in vitro cell-based assays allowing for quick screening and affordability and reliability for identifying drug candidates. In addition, the advantage of whole animal experiment is reliability for predicting drug candidate performance and potential toxicity in vivo.
Materials and Methods

Zebrafish Maintenance
Fish were maintained according to the standard method described in the zebrafish book [37] . AB strain fish was feed with dry food and Artemia salina twice a day. The night before breeding, males and females were separated into different tanks at a ratio of 1 male to 2 females. At the beginning of next light cycle, the males and females were allowed to mate in the same tank. Embryos were collected and cultured in petri dishes containing E3 water (5.0 mM NaCl, 0.17 mM KCl, 0.33 mM CaCl 2 and 0.33 mM MgSO 4 ) at 28 • C under a14 h on/10 h off light cycle. All animal experiments in this study were performed in accordance with the guidelines issued by the animal ethics committee of Chung Yuan Christian University (Number: CYCU10014).
Small Molecular Library
The CYCU-1120~1152 chemical library (Chung Yuan Christian University, Department of Bioscience Technology) was purchased from Enzo Life Sciences, Inc. (SCREEN-WELL ® Kinase Inhibitor library, BML-2832, Farmingdale, NY, USA) as the source of small molecules for the experiment. The active compounds in the library, alendronate (Enzo, PR-123, Farmingdale, NY, USA) and dorsomorphin (Sigma-Aldrich, P5499, Missouri, MO, USA) were dissolved in 100% dimethyl sulfoxide (DMSO) to 10 mM stock and finally were diluted with E3 water to working solution (at a range from 10 to 30 µM) for later experiment.
Calcein Labeling
Calcein staining is a fluorescent dye used for detecting calcium as an index of mineralization [38] . Due to considerations on the bone developmental progress, early observation with calcein staining would be insufficiently clear to show the mineralization. Zebrafish embryos aged at 7 dpf were immersed in 1% calcein working solution (Sigma-Aldrich, C0875, Missouri, MO, USA) for 10 mins and later washed with E3 water three times (each time 3 mins) to remove unbound dye. The fluorescent signals of the calcein-stained vertebrate column in the spinal region of zebrafish was observed at magnification of 10X under fluorescence microscopy (SMZ1500, Nikon, Tokyo, Japan) equipped with long pass green filter (excitation 480 ± 40 nm; emission 510 nm).
Small Molecular Screening
Synchronized embryos aged at 3 dpf were collected and arrayed by pipette. Twenty embryos per well were relocated into a 12-well plate for individual compound test. Small molecular compound stocks at 10 mM were diluted with E3 water to working concentrations ranged from 10 to 30 µM, and then added to embryos from 3 dpf onwards. According to our optimization on small molecular treatment for bone mineralization, fish could be treated as early as from 3 dpf onwards. The later the treatment was given, the less effect could be observed; however, early treatment might cause lethality. The toxicological effects of zebrafish were observed under the microscope from 3 dpf onwards until 7 dpf. During the screening period, dead fish were removed frequently and replaced the diluted compound to keep a more stable concentration of compound tested.
Real Time Quantitative PCR (RT-qPCR)
Total messenger RNA from zebrafish embryos aged at 3 dpf were extracted by the RNAZol ® RT (Invitrogen), and quantified with NanoDrop (Thermo Scientific, Waltham, MA, USA). RevertAid first cDNA synthesis kit (K1622, Fermentas, Waltham, MA, USA) was used to synthesize first-strand cDNA from total zebrafish RNA according to the manufacturer's instructions. RT-qPCR was performed using iQ SYBR Green Supermix (Bio-Rad Laboratories, Hercules, CA, USA) on a Bio-Rad iCycler using β-actin as control, and data were analyzed using the ∆∆Ct method [39] . The primer sequences used to perform quantitative real-time PCR are listed in Table 1 . 
Image Processing
Embryos and larvae were anesthetized with 0.16% tricaine methane sulfonate (MS222) in E3 water. Water was dispensed and the paralyzed embryos and larvae were moved into a plate containing 4% methylcellulose. Fish were orientated to an anterior-to-left and dorsal up position to facilitate image capture and comparison. Images were captured under florescence microscopy (SMZ1500, Nikon, Tokyo, Japan) mounted with a cool CCD (Evolution VF, Media Cybernectics, Rockville, MD, USA). The calcein stain-positive area of the vertebrate column was selected as region of interesting (ROI). The captured images were converted into binary black and white images by ImageJ software (version 1.44, https://imagej.nih.gov/ij/). Since the signal-to-noise ratio is high for calcein staining, we routinely calculate the calcein stain-positive area by using auto-threshold settings in ImageJ.
Statistical Analysis
The data was expressed as mean ± SD and the potential difference was tested by Student's-t test or one-way ANOVA pairwise comparison. The significance level was set at 5% (p < 0.05). The letter indicated different significance in figures; a, p < 0.5; b < 0.01; c < 0.005.
